My PCR
Create Account
Logo PCR

21 May 2026

Other coronary interventions

The impact of calcified and resistant lesions in clinical outcome of PCI

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: H. Soeholm, P. Degrell
Speakers: N. Gonzalo, A. Clement, G. Nardi, H. Cubero-Gallego, M. Kai, S. Kuramitsu, N. Amabile

Summary

Delve into the clinical implications of calcified and resistant coronary lesions on percutaneous coronary intervention (PCI) outcomes. This session presents key registry data and study results on intravascular lithotripsy and plaque modification techniques, highlighting their impact on patient prognosis and stent performance.

Presentations available when logged in:

  • One year EMPOWER CAD study results - Women with calcified CAD treated with intravascular lithotripsy
  • Patient outcomes with new C2+ intracoronary lithotripsy - Insights from the French academic registry
  • Plaque modification in calcified culprit lesion in STEMI: long-term results from ROCA-STEMI registry
  • Clinical outcomes of intravascular lithotripsy for calcified lesions with or without calcified nodules
  • Prognostic impact of stent underexpansion on outcomes of DES versus DCB in heavily calcified lesions
  • Calcified coronary lesions identification and quantification with X rays - The CALIQX pilot study
Related Content
FFRangio, are we ready for everyday practice? Refactory angina and coronary sinus reducer, from established applications to future outlooks IVL vs rotational atherectomy: head-to-head in calcified PCI
Recommended for you
AICT-AsiaPCR 2026 Call for Submissions CHIP-BCIS3: Left ventricular unloading in high-risk PCI VICTORY: Intravascular lithotripsy vs. super-high-pressure PTCA in calcified and refractory coronary lesions